Philips Healthcare is differentiating its PACS at RSNA 2008 by offering a wide variety of ancillary and complementary functions developed by other vendors but presented by Philips as optional software packages geared to work with its iSite system.
Philips Healthcare is differentiating its PACS at RSNA 2008 by offering a wide variety of ancillary and complementary functions developed by other vendors but presented by Philips as optional software packages geared to work with its iSite system.
The company is framing the strategy as spawning an IT-based "ecosystem" composed of about a dozen suppliers of software products. Customers can pick and choose from an array of possibilities. One is Amirsys' STATdx Diagnostic Decision Support System, which offers reference tools useful in the diagnostic process. Another is a suite of communications tools from Primordial, including an integrated instant messaging and e-mail program that keeps radiologists in contact with other providers.
The strategy provides Philips' customers and prospects an expanding set of capabilities with minimal in-house effort, thereby conserving the company's engineering resources to develop clinical applications. These include 3D visualization tools such as iSite Volume Vision, Pulmonary Embolism Assessment, and the work-in-progress CT Colonography product. The idea grew from the observation that an increasing number of vendors are going directly to customers, a trend that became apparent when Philips was called in to help integrate iSite with various software packages. Over time, the company has developed tight integrations and good relationships with these firms. This sparked the idea of expanding Philips' portfolio by offering choices developed by these companies.
STATdx is a logical complement to iSite. As the world's largest radiology reference database of diagnoses and images, the software helps radiologists form diagnoses faster, more accurately, and with greater confidence. With this and other add-ons to iSite, Philips seeks to empower its customers -- and itself.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.